Royal Women's Hospital Background: Preterm infants who require intubation and mechanical ventilation often receive surfactant therapy. We observed variations in clinical practice in our tertiary NICU with a proportion of intubated preterm infants not receiving surfactant before extubation. We therefore performed an audit to assess if those who did not receive surfactant after intubation did worse than those who did.
Royal Women's Hospital Background: Preterm infants who require intubation and mechanical ventilation often receive surfactant therapy. We observed variations in clinical practice in our tertiary NICU with a proportion of intubated preterm infants not receiving surfactant before extubation. We therefore performed an audit to assess if those who did not receive surfactant after intubation did worse than those who did.
Method: Retrospective review of all intubated and mechanically ventilated very and extremely preterm infants born less than 32 weeks' gestational age (GA) at a single tertiary NICU during 2014.
Results: Of the 271 very preterm infants admitted to the NICU, 138 (51%) were intubated and mechanically ventilated. 115 infants were included in the analysis of whom 94 (82%) received surfactant, 23 were excluded due to anomalies or a research intervention affecting surfactant therapy. Baseline characteristics did not differ between these groups, including GA (in weeks): 27.4+/−2.3 vs. 28.1+/−2.5 (mean+/−standard deviation; p = 0.20) and birth weight (in grams): 1070+/−366 vs. 1169 +/−572 (p = 0.32). There were no statistically significant differences found in mortality (p = 0.45), air leak requiring drainage (p = 0.12), incidence of BPD (p = 0.45) and ROP (p = 0.12). There was a trend towards shorter duration of ventilation in infants who did not receive surfactant (p = 0.07).
Conclusions: Clinical outcomes did not differ significantly between preterm infants who did or did not receive surfactant after intubation; our practice to not automatically give surfactant to preterm infants who do well immediately after intubation is supported by the results of this audit. Background: Diarrhoea is more likely to be a childhood disease. Newborn babies may present with diarrhoea due to carbohydrate intolerance, Listeria, or other causes of enteropathy, including cow's milk intolerance, transporter defects or ultrastructural abnormalities. Preterm babies are particularly at risk. We report a rare challenging case of in-utero diarrhoea of sufficient severity to need central line and parenteral nutrition.
A CASE REPORT OF A CHALLENGING CASE OF IN-
Method: A 33 weeks' baby had meconium stained liquor and was noted to pass profuse watery green stool since birth. The diarrhoea continued to pose a challenge well up to 3 months of age. Multiple investigations and trials of various formulas were required. Diarrhoea resolved with parenteral nutrition and recurred with breast or formula feed. Finally, she started tolerating gradual introduction of carbohydrate free, amino acid mixed with liquigen formula; especially prepared by the hospital pharmacy. Carbohydrate was slowly introduced and increased to normal levels as tolerated. At 6 months' age, she is on normal solid food and remains symptom free.
Results: An infective aetiology of diarrhoea including Listeria was ruled out. Upper and lower gastrointestinal endoscopy was normal and biopsies from gastric, duodenal and rectum indicated absence of plasma cells -a non specific finding. Investigations suggested osmotic diarrhoea, though the cause of diarrhoea was still not known.
Conclusions: There was no casual treatment for in-utero diarrhoea in this case, but the process of working up the causes of diarrhoea allowed us to gradually introduce a normal diet over time suggesting that our patient had a resolving enteropathy. Westmead Hospital Neonatal ICU Background: Epidermolysis Bullosa is a rare genetic disorder of skin or mucosa and may affect the eyes and nails. There is faulty keratin protein that functions as scaffolding for the skin, causing the skin to fall apart and form blisters. The spectrum of presentation ranges from mild cutaneous blisters to more debilitating mucosal involvement. We present two rare challenging cases of neonatal EB of sufficient severity; one needing opiate for pain management.
MANAGEMENT OF NEONATAL EPIDERMOLYSIS BULLOSA (EB) IN
Method: Both cases were term babies with a strong family history of EB. They were born by elective caesarean section and presented at birth with varying severity. Case 1 had blisters on hands and feet, progressed to form extensive cutaneous lesions and needed oral morphine and Panadol for pain management. Case 2 had mild skin pealing on palms and soles and developed cutaneous blisters on day 3.
Results: The cutaneous lesions were managed with multilayered wound dressing. Mepital applied around fingers and toes individually, to avoid digital fusion. Mepilex Lite, a secondary dressing to absorb the serous discharge. PolyMem, a very soft non adhesive roll to keep dressings intact. Tubifast was used to further secure dressing. Dressings were to remain intact for up to 72 hours. Any new lesion was burst with sterile needle to prevent progression of lesion.
Conclusions: The incidence of EB in Australia is 10 cases per million live birth. The 'feather touch' handling of the skin, innovative wound dressing and pain management is crucial part of management and also involves change in life style.
